To include your compound in the COVID-19 Resource Center, submit it here.

FDA releases Clolar data

There were no surprises in data released by FDA and Ilex about ILXO's Clolar clofarabine in advance of Wednesday's Oncologic Drugs Advisory Committee meeting. ODAC's discussion of Clolar is

Read the full 292 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE